130 related articles for article (PubMed ID: 36315051)
21. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
[TBL] [Abstract][Full Text] [Related]
22. The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.
Chen Y; Bai L; Zhang P; Zhao H; Zhou Q
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577150
[TBL] [Abstract][Full Text] [Related]
23. Shine, Shine, Ruthenium Caged Drug.
Etchenique R; Filevich O
Photochem Photobiol; 2023 Mar; 99(2):860-862. PubMed ID: 36562218
[TBL] [Abstract][Full Text] [Related]
24. Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release.
Hufziger KT; Thowfeik FS; Charboneau DJ; Nieto I; Dougherty WG; Kassel WS; Dudley TJ; Merino EJ; Papish ET; Paul JJ
J Inorg Biochem; 2014 Jan; 130():103-11. PubMed ID: 24184694
[TBL] [Abstract][Full Text] [Related]
25. NIR-Light-Driven Generation of Reactive Oxygen Species Using Ru(II)-Decorated Lipid-Encapsulated Upconverting Nanoparticles.
Meijer MS; Talens VS; Hilbers MF; Kieltyka RE; Brouwer AM; Natile MM; Bonnet S
Langmuir; 2019 Sep; 35(37):12079-12090. PubMed ID: 31389710
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization, photophysical and electrochemical properties, and biomolecular interaction of 2,2'-biquinoline based phototoxic Ru(II)/Ir(II) complexes.
Das U; Paira P
Dalton Trans; 2023 Sep; 52(36):12608-12617. PubMed ID: 37314097
[TBL] [Abstract][Full Text] [Related]
27. Ruthenium-Containing Block Copolymer Assemblies: Red-Light-Responsive Metallopolymers with Tunable Nanostructures for Enhanced Cellular Uptake and Anticancer Phototherapy.
Sun W; Parowatkin M; Steffen W; Butt HJ; Mailänder V; Wu S
Adv Healthc Mater; 2016 Feb; 5(4):467-73. PubMed ID: 26680371
[TBL] [Abstract][Full Text] [Related]
28. Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex.
Brabec V; Pracharova J; Stepankova J; Sadler PJ; Kasparkova J
J Inorg Biochem; 2016 Jul; 160():149-55. PubMed ID: 26778426
[TBL] [Abstract][Full Text] [Related]
29. Anticancer metallodrugs: where is the next cisplatin?
Hanif M; Hartinger CG
Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
[TBL] [Abstract][Full Text] [Related]
30. Red-Light Activation of a Microtubule Polymerization Inhibitor via Amide Functionalization of the Ruthenium Photocage.
Bretin L; Husiev Y; Ramu V; Zhang L; Hakkennes M; Abyar S; Johns AC; Le Dévédec SE; Betancourt T; Kornienko A; Bonnet S
Angew Chem Int Ed Engl; 2024 Jan; 63(5):e202316425. PubMed ID: 38061013
[TBL] [Abstract][Full Text] [Related]
31. Steric and Electronic Factors Associated with the Photoinduced Ligand Exchange of Bidentate Ligands Coordinated to Ru(II).
Albani BA; Whittemore T; Durr CB; Turro C
Photochem Photobiol; 2015; 91(3):616-23. PubMed ID: 25403564
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity, cellular uptake, and subcellular localization of a nitrogen oxide and aminopropyl-β-lactose derivative ruthenium complex used as nitric oxide delivery agent.
Dos Santos JS; Ramos LC; Ferreira LP; Campo VL; de Rezende LCD; da Silva Emery F; Santana da Silva R
Nitric Oxide; 2019 May; 86():38-47. PubMed ID: 30790696
[TBL] [Abstract][Full Text] [Related]
33. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
Fayad C; Audi H; Khnayzer RS; Daher CF
J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
[TBL] [Abstract][Full Text] [Related]
34. Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.
Papish ET; Oladipupo OE
Curr Opin Chem Biol; 2022 Jun; 68():102143. PubMed ID: 35483128
[TBL] [Abstract][Full Text] [Related]
35. A photoactivatable chemotherapeutic Ru(II) complex bearing bathocuproine ligand efficiently induces cell death in human malignant melanoma cells through a multi-mechanistic pathway.
Elias MG; Mehanna S; Elias E; Khnayzer RS; Daher CF
Chem Biol Interact; 2021 Oct; 348():109644. PubMed ID: 34508709
[TBL] [Abstract][Full Text] [Related]
36. Anticancer cationic ruthenium nanovectors: from rational molecular design to cellular uptake and bioactivity.
Mangiapia G; Vitiello G; Irace C; Santamaria R; Colonna A; Angelico R; Radulescu A; D'Errico G; Montesarchio D; Paduano L
Biomacromolecules; 2013 Aug; 14(8):2549-60. PubMed ID: 23705931
[TBL] [Abstract][Full Text] [Related]
37. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
Pal M; Nandi U; Mukherjee D
Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous formation in the dark, and visible light-induced cleavage, of a Ru-S bond in water: a thermodynamic and kinetic study.
Bahreman A; Limburg B; Siegler MA; Bouwman E; Bonnet S
Inorg Chem; 2013 Aug; 52(16):9456-69. PubMed ID: 23909908
[TBL] [Abstract][Full Text] [Related]
40. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
